| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.2 | 0.004 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.092 | 0.004 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.089 | 0.004 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.006 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |